Your browser doesn't support javascript.
loading
CD52 is a molecular target in advanced systemic mastocytosis.
Hoermann, Gregor; Blatt, Katharina; Greiner, Georg; Putz, Eva Maria; Berger, Angelika; Herrmann, Harald; Cerny-Reiterer, Sabine; Gleixner, Karoline V; Walz, Christoph; Hoetzenecker, Konrad; Müllauer, Leonhard; Reiter, Andreas; Sotlar, Karl; Sexl, Veronika; Valent, Peter; Mayerhofer, Matthias.
Affiliation
  • Hoermann G; Department of Laboratory Medicine, matthias.mayerhofer@meduniwien.ac.at.
  • Blatt K; Department of Internal Medicine I, Division of Hematology and Hemostaseology.
  • Greiner G; Department of Laboratory Medicine.
  • Putz EM; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria;
  • Berger A; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria;
  • Herrmann H; Ludwig Boltzmann Cluster Oncology, Vienna, Austria;
  • Cerny-Reiterer S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Ludwig Boltzmann Cluster Oncology, Vienna, Austria;
  • Gleixner KV; Department of Internal Medicine I, Division of Hematology and Hemostaseology.
  • Walz C; Institute of Pathology, Ludwig Maximilians University Munich, Munich, Germany;
  • Hoetzenecker K; Department of Surgery, Division of Thoracic Surgery, and.
  • Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria;
  • Reiter A; Medizinische Universitätsklinik, Universitätsmedizin Mannheim, Mannheim, Germany; and.
  • Sotlar K; Institute of Pathology, Ludwig Maximilians University Munich, Munich, Germany;
  • Sexl V; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria;
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Ludwig Boltzmann Cluster Oncology, Vienna, Austria;
  • Mayerhofer M; Ludwig Boltzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria matthias.mayerhofer@meduniwien.ac.at.
FASEB J ; 28(8): 3540-51, 2014 Aug.
Article de En | MEDLINE | ID: mdl-24760752
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycoprotéines / Antigènes CD / Mastocytose généralisée / Thérapie moléculaire ciblée / Anticorps monoclonaux humanisés / Antigènes néoplasiques / Antinéoplasiques Type d'étude: Prognostic_studies Langue: En Journal: FASEB J Sujet du journal: BIOLOGIA / FISIOLOGIA Année: 2014 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycoprotéines / Antigènes CD / Mastocytose généralisée / Thérapie moléculaire ciblée / Anticorps monoclonaux humanisés / Antigènes néoplasiques / Antinéoplasiques Type d'étude: Prognostic_studies Langue: En Journal: FASEB J Sujet du journal: BIOLOGIA / FISIOLOGIA Année: 2014 Type de document: Article